Debt-free, Large Equity BaseZero debt and a large equity base provide durable financial flexibility and low solvency risk, enabling the company to fund capex, withstand shocks or pursue strategic transactions without near-term refinancing. This structural strength preserves optionality during execution over months.

Strong Recent Revenue GrowthA +24.9% top-line increase signals sustained demand or improving commercial traction in its specialty chemicals/fumigation markets. Continued revenue expansion provides scale potential, which over several quarters can support margin recovery and more efficient fixed-cost absorption.

Positive EBITDA Indicates Core Earnings PotentialPositive EBITDA despite negative EBIT suggests core operations generate cash-like earnings before depreciation/amortization. If management can control below-EBIT costs or rationalize non-cash charges, EBITDA conversion could drive sustainable operating cash flow improvement over the medium term.

Bears Say

Very Weak MarginsNear-zero gross margin and negative EBIT indicate structurally weak profitability that limits the company's ability to absorb cost shocks, invest in growth, or improve ROE. Without meaningful margin expansion, top-line growth may not translate into durable shareholder returns.

Recurring Negative Operating/free Cash FlowPersistent negative OCF and free cash flow show the business is not self-funding. Over 2–6 months continued cash outflows constrain reinvestment, raise the need for working-capital financing or asset sales, and increase execution risk despite a debt-free balance sheet.

Extremely Low Return On EquityA ROE near zero indicates the large equity base is not generating meaningful returns for shareholders. Structurally low ROE implies capital allocation or operational inefficiencies; reversing this requires sustained profit improvement or a change in capital structure or strategy.

Uniphos Enterprises Limited News

Uniphos Enterprises Closes Trading Window Ahead of Unaudited Results

Uniphos Enterprises Limited ( ($IN:UNIENTER) ) has shared an announcement. Uniphos Enterprises Limited has announced that its trading...

2M ago

UNIENTER FAQ

What was Uniphos Enterprises Limited’s price range in the past 12 months?

Uniphos Enterprises Limited lowest stock price was ₹101.00 and its highest was ₹172.90 in the past 12 months.

What is Uniphos Enterprises Limited’s market cap?

Uniphos Enterprises Limited’s market cap is ₹8.17B.

When is Uniphos Enterprises Limited’s upcoming earnings report date?

Uniphos Enterprises Limited’s upcoming earnings report date is May 21, 2026 which is in 88 days.

How were Uniphos Enterprises Limited’s earnings last quarter?

Uniphos Enterprises Limited released its earnings results on Feb 06, 2026. The company reported -₹0.145 earnings per share for the quarter, missing the consensus estimate of N/A by -₹0.145.

Is Uniphos Enterprises Limited overvalued?

According to Wall Street analysts Uniphos Enterprises Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Uniphos Enterprises Limited pay dividends?

Uniphos Enterprises Limited pays a Annually dividend of ₹0.5 which represents an annual dividend yield of 0.34%. See more information on Uniphos Enterprises Limited dividends here

What is Uniphos Enterprises Limited’s EPS estimate?

Uniphos Enterprises Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Uniphos Enterprises Limited have?

Uniphos Enterprises Limited has 69,545,845 shares outstanding.

What happened to Uniphos Enterprises Limited’s price movement after its last earnings report?

Uniphos Enterprises Limited reported an EPS of -₹0.145 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 2.663%.

Which hedge fund is a major shareholder of Uniphos Enterprises Limited?

Currently, no hedge funds are holding shares in IN:UNIENTER

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Uniphos Enterprises Limited

Uniphos Enterprises Limited engages in trading of chemicals and other products in India. The company also invests in quoted and unquoted securities. Uniphos Enterprises Limited was incorporated in 1969 and is based in Mumbai, India. Uniphos Enterprises Limited is a subsidiary of Nerka Chemicals Private Limited.